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Background: Previous reports showed the presence of limited numbers of stem cells in neonatal murine cochlear
sensory epithelia and these cells are progressively lost during the postnatal development. The goal of this study
was to investigate whether stem cells can be derived from mature mouse cochleae under suspension culture
conditions, and to analyze the expression of the stem cell and inner ear progenitor cell markers in cells dissociated
from neonatal and adult mouse organs of Corti.
Methods: Organs of Corti were dissected from postnatal day 1 (P1) or postnatal day 60 (P60) mouse. The
dissociated cells were cultivated under suspension cultures conditions. Reverse transcription-polymerase chain
reaction (RT-PCR) and immunocytochemistry were conducted for phenotype characterization.
Results: The number of cochlear stem cells (otospheres) yielded from P1 organ of Corti was significantly higher
than that of the P60 organ of Corti. RT-PCR analyses showed that the stem markers, such as nanog, sox2, klf4, and
nestin can be found to be distributed similarly in the cells derived from both of organisms, but the inner ear
developmental/progenitor cell markers showed lower expression in P60 organ of Corti compared to P1.
Immunocytochemistry results also revealed the evidence that P60 otospheres lacking of differentiation potential
in vitro, which opposed to the strong differentiation potential of otospheres at P1 stage.
Conclusions: Our findings suggest that the loss of numbers and features of stem cells in the adult organ of Corti is
associated with the substantial down-regulation of inner ear progenitor key-markers during maturation of the cells
in organ of Corti.
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The mammalian inner ear has very limited ability to re-
generate lost sensory hair cells [1,2]. While previous
studies demonstrate that early postnatal cochlea harbors
stem/progenitor-like cells and show a limited regenera-
tive/repair capacity [3-13], and these properties, how-
ever, are progressively lost later during the postnatal
development of the inner ear [5].
Despite the pluripotent differentiation potential of
these cells, recovery does not occur to any significant ex-
tent after damage to hair cells in the adult mammalian
cochlea [3]. Nevertheless, some reports show the pres-
ence of limited numbers of nestin-positive stem cells in* Correspondence: yzzhang@dhu.edu.cn
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unless otherwise stated.adult mouse organ of Corti [5], suggesting that there
may be some intrinsic potential for repairing hair cells.
Therefore, it would be of great interest to explore
whether there is the ability of sphere formation from
cells harvested during later postnatal and mature stages.
It is well known that the adult mammalian cochleae
lack regenerative ability and the irreversible degener-
ation of cochlear sensory hair cells leads to permanent
hearing loss [14], but little is known about the genes and
pathways that are potentially involved in this difference
of the regenerative/repair potentialities between early
postnatal and adult mammalian cochlear sensory epithe-
lia (SE) [14]. The aims of this study are: 1) To investigate
whether some remnants of regenerative ability of quies-
cent progenitor/stem cells can be isolated from mature
cochlea, we compare the sphere-forming capabilities of
cultured cells derived from P1 and P60 SE; 2) To explore. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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progenitor cells maintenance and the capacity of
regeneration/repair between P1 and P60 SE-derived
cells. We examined the expression of a number of genes
that were known as stem markers and early inner ear cell
markers. These genes have been shown to be linked into
known networks and pathways implicated in the mamma-
lian cochlea. In addition, we investigate whether these
cells can be differentiated into hair cells and supporting
cells in vitro using immunocytochemistry.
Materials and methods
Animals
P1 and P60 C57/BL6 mouse pups (Slac laboratory animal,
Shanghai, China) from different litters were used. Animals
were housed with mothers in Animal House (College of
Chemistry, Chemical Engineering and Biotechnology,
Donghua University, China). During this study, animal
care and use were in strict accordance with the animal
welfare guidelines of the Helsinki Declaration.
Cell culture procedure
Dissociated cell cultures were obtained under aseptic con-
ditions from P1 and P60 mice as previously described [15]
(Figure 1). In brief, SE sheets were isolated from cochleae
in Hanks’ buffered salt solution (HBSS, Invitrogen) at 4°C,
PH 7.4. Tissues were subjected to 0.125% trypsin in PBS
solution (Invitrogen) for 15 min, at 37°C, then blocked by
trypsin inhibitor and DNAse I solution (Sigma). After gen-
tly mechanical dissociation, the pellets were suspended in
DMEM/F12 (Dulbecco’s Modified Eagle Medium: Nutrient
Mixture F-12) 1:1 Mixture (Invitrogen) supplemented with
N2 and B27 supplements (Invitrogen), EGF (20 ng/ml)
(R&D Systems), bFGF (10 ng/ml) (Wako, Japan), IGF-1
(50 ng/ml) (R&D Systems), ampicillin (50 ng/ml; Sigma)
and heparin sulphate (50 ng/ml) (Sigma). The suspension
was passed through a 70 μm cell strainer (BD Labware)
into 6 well plastic Petri dishes (Greiner). Cell cultures were
incubated under 37°C, 5% CO2, half of the medium was re-
placed every 2 days. At day 3, cell suspension was replated
in new Petri dishes, the attached cells were abandoned. The
suspending otospheres obtained from P1 or P60 organ of
Corti were assessed in later experiments. For analysis of cell
differentiation, we maintained the attached sphere-derivedFigure 1 Tissue dissection and cell handling procedure.cells in a humidified incubator in a 5% CO2 at 37°C in differ-
entiation medium consisting of DMEM/F12 mixed (1:1)
supplemented with N2 and B27 (medium and supplements
were from Invitrogen), 10% fetal bovine serum (Invitrogen),
and ampicillin (50 ng/ml; Sigma). Half of the medium was
replaced every 2 days. The differentiated cells were analyzed
by immunofluorescence 7 days after plating.
Cell yield and viability
The yield and cell viability were determined by using trypan
blue vital staining. Four cochleae were dissected from
P1 and P60 mice, respectively. The dissociated organ of
corti-derived cells were seeded under suspension cul-
ture condition, 100 μl cell suspension of each condition
was treated separately with 100 μl of 0.4% trypan blue.
Using bright field optics, numbers of stained cells with
intact plasmamembranes were determined.
Cell proliferation ability was evaluated by 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) solution (MTT assay kit, Sigma, USA). Briefly,
the dissociated organ of Corti-derived cells were plated
at 1000 cells/well in 96 well dishes. After the predeter-
mined time points of incubation, the medium on these
samples was removed and 10 μl of 5 mg/ml MTT solu-
tion was added and assayed according to the manufac-
turer’s instructions. Optical density of solutions in
wells was measured at 570 nm using a photometer
(MK3 Multilabel Plate Reader, Thermo, USA).
RT-PCR assay
Total RNA was isolated from P1 or P60 mice SE and
SE-derived otospheres respectively by using RNeasy
Mini Kits (Qiagen), and a mouse embryonic stem cells
(ESc) line, G4-2, was taken as positive control to show
stem markers. We used 500 ng of total RNA from each
group for reverse transcription (RT) by using Superscript
III (Invitrogen). We determined the expression of mRNA of
stem markers (nanog, sox2, oct3/4, klf4, c-myc and nestin),
early inner ear cells markers (jagged1, pax2, brn3.1, bmp7,
myosin 7a and p27kip1). Polymerase chain reaction (PCR)
analysis was performed by using the following primers
pairs: nanog (fw: AGG GTC TGC TAC TGA GAT GCT
CTG, rv: CAA CCA CTG GTT TTT CTG CCA CCG);
sox2 (fw: TAG AGC TAG ACT CCG GGC GAT GA, rv:
Figure 2 MTT assays of the cell proliferation abilities of P1 and
P60 organ of Corti-derived cells. Data represent the cell
proliferation at 1 to 7 days, and which is taken as a mean value of
the triplicates (n = 6).
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CCA ACT TGA ACA TGC CCG GAC TT, rv: TCT GCT
TAA AGG CAT ACT TGG GA); oct3/4 (fw: TCT TTC
CAC CAG GCC CCC GGC TC, rv: TGC GGG CGC
ACA TGG GGA GAT CC); c-myc (fw: TGA CCT AAC
TCG AGG AGG AGC TGG AAT C, rv: TTA TGC ACC
AGA GTT TCG AAG CTG TTC G); nestin (fw: GAT
CGC TCA GAT CCT GGA AG, rv: AGA GAA GGA
TGT TGG GCT GA); jagged1 (fw: GGT CCT GGA TGA
CCA GTG TT, rv: GTT CGG TGG TAA GAC CTG GA);
pax2 (fw: CCC ACA TTA GAG GAG GTG GA, rv: GAC
GCT CAA AGA CTC GAT CC); brn3.1 (fw: GTC TCA
GCG ATG TGG AGT CA, rv: TCA TGT TGT TGT
GCG ACA GA); bmp7 (fw: TCT TCC ACC CTC GAT
ACC AC, rv: GCT GTC CAG CAA GAA GAG GT);
myosin 7a (fw: CAC TGG ACA TGA TTG CCA AC, rv:
ATT CCA AAC TGG GTC TCG TG); p27kip1 (fw: ATT
GGG TCT CAG GCA AAC TC, rv: TTC TGT TCT GTT
GGC CCT TT); GAPDH (fw: GGG TGT GAA CCA CGA
GAA AT, rv: ACA GTC TTC TGG GTG GCA GT). The
RT-PCR experiments were independently repeated 3 times
with the same total RNA material. Control RCR reactions
were performed lacking cDNA (RT-).
Immunochemistry procedure
To characterize the expression of stem and inner ear
progenitor cell maker expression, the first propagation
otospheres derived from P1 or P60 organs of Corti were
selected for immunostaining analysis. The primary anti-
bodies used were as follows, mouse monoclonal antibody
for Oct3/4 (1:500, Santa Cruz Biotechnology, Santa Cruz,
CA), for Nestin (1:500, BD Biosciences); goat polyclonal
antibody for Sox2 (1:200, Santa Cruz Biotechnology); Pax2
(1:200, BD Biosciences) and for Jagged1 (1:200, Santa Cruz
Biotechnology).
The differentiative abilities of P1 and P60 otospheres
were characterized by immunocytochemistry using inner ear
cell specific markers. After fixation in 4% paraformaldehyde,
cells were washed with 0.1 M phosphate-buffered saline
(PBS, PH 7.4) for 15 min. Nonspecific staining was blocked
in PBS containing 0.2% Triton X-100 (Sigma) and 10% horse
serum solution for 30 min. Primary antibodies Myosin7a
(1:500, Proteus Biosciences, Ramona, CA), p27kip1 (1:200,
NeoMarkers, Fremont, CA), and βIII-tubulin (1:500, Santa
Cruz Biotechnology, Santa Cruz, CA) were applied overnight
in PBS with 10% horse serum and 0.2% Triton X-100 at 4°C.
After 3 times wash, FITC (fluorescein isothiocyanate)
or TRITC (Tetramethyl Rhodamine) conjugated second
antibodies (Invitrogen) were added for 60 min, counterstain-
ing with DAPI (4′, 6-diamidino-2-phenylindole) (Invitrogen)
was performed to visualize cell nuclei. Specimens were
examined by confocal microscope (Leica). Negative con-
trol experiments were performed as above by omitting
the primary antibodies.Statistical analysis
Quantitative data are expressed as the mean ± SD. The
statistical process was examined by student’s unpaired
two-tailed t-test. Significant differences are indicated
by * (p < 0. 01).
Results
Cell viability and proliferation
By staining with trypan blue, we observed that the viable
cells from P1 organ of Corti 9.6 ± 0.9 (mean ± SD) × 104
were nearly 2-fold higher compared to P60 5.4 ± 1.1
(mean ± SD) × 104. MTT assay had been used to inves-
tigate rates of cell proliferation of P1 and P60 organ of
Corti-derived cells. We observed that significantly en-
hanced proliferation of both cells from day 1 to 3, and
maximum effect was produced at day 3 (Figure 2). P1
cells showed increasing in proliferation at all time
points, while enhanced proliferation was not observed
in P60 cells, which changed to reducing from day 3 to
5 and kept stably from day 5 to 7.
Otospheres harvested from P1 and P60 organ of Corti
As shown in Figure 3, cells dissociated from P1 organ of
Corti formed nice spheres, and they appeared to continue
to proliferate during the course of culture at least 1 week
(Figure 3A, A׳). While cells dissociated from P60 organ of
Corti failed to form nice spheres during culture, only very
few spheres could be found in several attempts we made
(Figure 3B, B׳).
As for the otospheres number analysis, significant dif-
ference in sphere-forming cells number between P1 and
P60 organ of Corti was observed in present study
(Table 1). In contrast to P60 organ of Corti, the neonatal
organ of Corti yielded much more sphere-forming cells,
and this situation was maintained during the period of
study, no any morphological sign of differentiation was
Figure 3 Images represent the otospheres of culturing dissociated P1 or P60 organ of Corti. (A) One day cultured cells dissociated from
P1 organ of Corti; (A׳) Otospheres from suspension culture seven days of dissociated P1 organ of Corti; (B) One day culture of cells dissociated
from P60 organ of Corti; (B׳) After seven days culture, only very few and small sphere cells were observed from dissociated P60 organ of Corti;
Scale bar = 50 μm.
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spheres from P1 could be passaged several propaga-
tions, but we could not acquire second generation of
otospheres from P60.
Expression of stem and inner ear progenitor cell markers
in SE and SE-derived otospheres harvested from P1 and
P60 cochleae
The obvious reduction of the ability of cochlear organs
from P60 mice to generate otospheres raises the question
whether this loss of regenerative capacity is reflected in the
expression levels of marker genes for stem cells and/or
inner ear progenitor cells. We detected the expression of
mRNA of stem markers, nanog, sox2, klf4, nestin, and early
otic cell markers, pax2, jagged1, brn3.1, bmp7, p27kip1,
and myosin7a (Figure 4). Oct3/4 was found only expressed
in ESc but not in otospheres. No c-myc expression wasTable 1 Otosphere numbers harvested from P1 and
P60 cochleae
Age Number of




P1 3406 ± 245* 4 Suspension culture
7 days
P60 2 ± 1 4 Suspension culture
7 days
Data are mean ± SD. Significant differences are indicated by *(p < 0.01).detected in this study. Indeed, the mRNA expression of all
stem cell markers that we investigated was stably main-
tained in P1 and P60 SE as well as SE-derived otospheres
(Figure 4). However, we found inner ear developmental/
progenitor markers, i.e. pax2, jagged1, bmp7, brn3.1,
p27kip1 and myosin7a showed lower expression in P60 SE
and SE-derived otospheres compared with P1 (Figure 4).
Immunocytochemistry results
Otospheres from P1 and P60 organs of Corti exhibited
the expression of stem markers, Sox2 (Figure 5A, A׳)
and Nestin (Figure 5B, B׳) as well as inner ear progeni-
tors, Pax2 (Figure 5C, C׳) and Jagged1 (Figure 5D, D′),
and no expression of Oct3/4 (data were no shown). As
for P1 SE-derived otospheres, Sox2 was found 30 ± 3.4
(mean ± SD)% of total otospheres, Nestin was seen in
91 ± 12.4%, Pax2 was 18 ± 10.2% and Jagged1 was found
in all otospheres. However, only very few otospheres from
P60 organs of Cotri could be obtained.
As for cell differentiation, our results showed the staining
of protein markers for inner ear cells upon culturing of P1
and P60 otospheres in differentiation medium (Figure 6).
All markers employed: Myosin7a (Figure 6A and A׳) for
hair cells, p27kip1 (Figure 6B and B׳) for supporting
cells, and βIII-tubulin (Figure 6C and C׳) for neural
cells (myosin7a in cell processes, βIII-tubulin in the
plasma membrane and neurite, and nuclear localization
Figure 4 RT-PCR analysis of the expression of stem cell and inner ear progenitor cell markers in the P1 and P60 SE, and the SE derived
otospheres. GAPDH expression analysis is shown as reference, and RT- is shown as negative control. ESc: embryonic stem cells; SE: sensory
epithelia; Oto: otospheres.
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phenotype of the two kinds of otospheres and their
commitment to differentiate to different cell types of the
inner ear. However, only very few immunostaining positive
cells were observed in the differentiated cells from P60
otospheres. We deduced that the lack of demonstration of
hair cell, neural cell and supporting cell differentiation
from P60 otospheres is most probably due to their limited
cell number. The other reason may also be related to the
relatively maturation of P60 cochlea compared with P1.
Discussion
Hearing loss is often caused by loss of hair cells (HCs)
due to a variety of factors that generate oxidative stress
including noise, ototoxic drugs, cisplatin or aging, etc.
[2,16]. The primary cause of hearing loss is the damage orFigure 5 Immunostaining for stem markers: Sox2 (A, A׳) and Nestin (B
Jagged1 (D, D׳) in P1 and P60 otospheres, respectively. DAPI identifiesdeath of the sensory cells in the auditory part of the inner
ear, i.e. the cochlea. In mammals, HCs are produced only
during embryonic development and do not regenerate,
if these cells are lost during postnatal and adult life,
the result is profound sensorineural deafness [17]. The
adult mammalian cochlea lacks regenerative ability and the
irreversible degeneration of cochlear sensory hair cells leads
to permanent hearing loss [17]. The previous studies show
that early postnatal cochleae harbor stem/progenitor-
like cells and show a limited regenerative/repair capacity
[4,7-15,17,18], however, these properties are progressively
lost later during the postnatal development [5]. Further-
more, the discovery of stem cells in the adult mouse ut-
ricular SE spurred great interest to investigate whether
other parts of the inner ear also harbor stem cells that can
be isolated by in vitro culture [19]. In contrast to adult, B׳), and inner ear progenitor cell markers, Pax2 (C, C׳) and
the cell nucleus in blue. Scale bar = 50 μm.
Figure 6 Immunofluorescence of differentiated cells derived from P1 and P60 otospheres. Myosin7a positive cells (green) were found in
P1 (A) and P60 (A׳) differentiated otospheres; p27kip1 labels supporting cell nuclei, as shown in P1 (B) and P60 (B׳); βIII-tubulin positive cells were
observed from differentiated P1 (C) and P60 (C׳) otospheres. DAPI identifies the cell nucleus in blue. Scale bar = 50 μm.
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has very limited capabilities to form sphere cells [5]. Little
is known about the genes and pathways that are poten-
tially involved in this difference of the regenerative/repair
potentialities between early postnatal and adult mamma-
lian cochlear SE.
To investigate whether some remnants of regenerative
ability of quiescent progenitor/stem cells can be isolated
from mature cochlea, we compare the cell viability as well
as sphere-forming capabilities of cultured cells derived from
P1 and P60 organs of Corti, respectively. A notable ob-
servation was that the cell viability of P1 organ of
Corti-derived cells were 2-fold higher than P60, indicatingthe cell populations have a wide-ranging alterations at dif-
ferent ages. MTT assay demonstrated that P1 cells showed
marked enhancement of proliferative activity during expan-
sion culture in vitro, which suggested that P1 cells have
higher potential for proliferation compared to P60 cells.
As for the sphere-forming capabilities, we only observed
very few sphere formation (2 ± 1, n = 5) from four dissoci-
ated P60 SE, which can be negligible compared to P1 tis-
sues (3406 ± 245, n = 5), indicating that the stem cells of
the auditory system disappear during the mature stage.
Our result is consistent with the data of Oshima’s report
that the total otosphere numbers are indeed decreased
from P21 to P42 organ of Corti and spiral ganglion [5].
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sphere formation in the adult organ of Corti. We first rea-
son that the observed loss of sphere formation is reflected
the cell number loss during mature. However, when we
seeded the same number of cells derived from P1 or P60
cochleae, respectively, we still found that the stark loss of
capacity for sphere formation in P60 stage. As for the
propagation culture, we found otospheres from P1 can
be passaged for several propagations and showed high
self-renewal ability and viability. Wherein, we could not
acquire second propagation of sphere-forming cells from
dissociated primary ototspheres at P60. The reason may
be that the self-renewal capacity of the limited numbers of
stem cells in adult organ of Corti is progressively lost dur-
ing the postnatal development. We hypothesize that as an
alternative to the loss of stem cells might be interpreted as
a loss of stem cell features. The hypothesis is further con-
firmed by the analysis of RT-PCR expression using stem
cell and inner ear progenitor cell markers. The diminish-
ing stem cell features at P60 cochlear cells can provide a
reasonable explanation for the long known regenerative
inability of the maturing cochlea [20-24]. This view is sup-
ported by our observation that the expression of mRNA
of inner ear developmental/progenitor became lower from
P1 to P60. Future study will perform real-time PCR or
western-blotting experiments to complement the quanti-
tative data. We hypothesize that the loss of stem cells or
the loss of stem cell features in the adult organ of Corti is
accompanied by a substantial reduction at the expression
level of inner ear progenitor cell markers. Whereas the
sustained expression of stem cell markers between P1 and
P60 tissues is an indication of the maintenance of stem-
ness in mammalian SE, but it is still know little about how
to stimulate these quiescent stem cells to self-renewal and
proliferate in maturing stage [25].
C57/BL6 is most widely used inbred strain in hearing
research. The C57/BL6 mice exhibit a high frequency
hearing loss by 3–6 months of age that progresses to a
profound impairment by 15 months. This strain has a
known age associated hearing loss due to cdh23ahl [26].
Because of the possibility of potential influence of this in
ours studies, we examined the otospheres from P 60 mice.
We have performed the experiments on ICR mice, and
found the expression of stem cell and inner ear progenitor
cell markers are associated with age (data were not shown).
Because of the possibility of strain differences, it would be
great interest to examine the cochlear stem cell phenotypes
from different strains, i.e. ICR, BALB/c and C57/BL6 mice
in future study.
The results of this approach may provide directions
for future investigations into the understanding of the
known difference in the ability for regeneration/repair
between the early postnatal/developing and adult cochleae.
In addition, it would be interesting in future studies toremove or reduce the potential mechanisms of repression
to active these stem cells [27], and it is worth pursuing the
best growth factor combination that potentially leads to in-
creased cell survival, proliferation and differentiation. Other
method, such as gene transfer [28] or iPS cell technology
[29,30] can be performed to achieve the goal.
Conclusion
Sphere-forming stem cells from the mouse inner ear
are an important tool for the development of cellular
replacement strategies of damaged inner ears and are a
bona fide progenitor cell source for transplantation
studies. Dissociated P60 organ of Corti produced very
few otospheres in vitro, expressing stem markers, such
as sox2 and nestin similarly to P1 SE and otospheres.
However, inner ear developmental/progenitor cell show
lower expression in P60 stage compared with to P1, which
may be contribute the reducing sphere-forming ability from
P60 SE. And the lower number of cells for P60 otospheres
may relate to its lack of differentiation potential in vitro, as
opposed to the strong differentiation potential observed
in vitro for P1 otospheres. However, the limited sphere cell
number and restricted differentiation potential observed by
us at P60 organ of Corti reinforce this organism as potential
experimental studies to search for the mechanisms for
organ of Corti regeneration in mammalian cochlea.
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